Video summary

EP237: Brain Folate Connection: Cerebral Folate, FRAAs, and Leucovorin - Emily Gutierrez, DNP

Main summary

Key takeaways

Wellness and Self-Improvement

Wellness strategies, self-care techniques, and productivity tips (key takeaways)

1) Focus on “cerebral folate deficiency” (CFD) and folate transport into the brain

  • Key concept: Blood folate can appear normal while cerebrospinal fluid (CSF)/brain folate is low.
  • Mechanism discussed: Folate receptor alpha autoantibodies (FRAAs) may bind/block folate transport at the choroid plexus, limiting brain folate availability.
  • Practical clinical implication (as described):
    • Consider folate transport issues in neurodevelopmental and neuropsychiatric presentations
    • Especially when immune/neuroinflammatory stress is suspected

2) Use a root-cause framework: “immune + mitochondrial + nutrition” (not folate alone)

The approach is described as a functional medicine matrix:

  • Reduce neuroinflammation/oxidative stress
  • Address infection/co-infections (including sources that can be difficult to detect)
  • Optimize mitochondrial function/energy
  • Correct cofactor nutrients before high-dose folate interventions

Emphasis: CFD-related symptoms are treated as multi-factor, not a single-deficiency explanation.

3) Prefer folinic acid (leucovorin/Lucovorin) over folic acid (in this context)

  • Rationale given:
    • Folic acid is synthetic and requires multiple conversion steps
    • Folinic acid (lucovorin) and methylated folate are “active forms” that may bypass problematic conversion/transport steps
  • Evidence mentioned (as claimed in subtitles):
    • An Italian randomized study described where pregnant women with folate antibodies had lower autism diagnosis rates when treated with folinic acid vs folic acid

4) “Prerequisite steps” before high-dose folinic acid

Before introducing lucovorin (and follow-up folate dosing), the guest emphasizes:

  • B12 first (to reduce risk of “folate trapping” / support remethylation)
  • Inflammation and infection first (optimize the immune environment)
  • Mitochondrial support (transport into the brain requires energy)
  • Then slow titration of folinic acid

5) Test-guided treatment: FRAT testing and interpretation

  • FRAT test (ReliGen; “fratt.com” referenced):
    • Produces positive/negative results and a numeric value
    • Includes qualitative categories discussed (e.g., blocking/binding/“floating”)
  • Clinician guidance described:
    • Higher numbers → more severe presentation
    • The “floating/soluble” form is discussed as potentially most severe
  • Tailoring described: treatment intensity can be adjusted by result severity
  • Caveat acknowledged: clinicians may treat without FRAT testing depending on risk/benefit and clinical picture

6) Titrate slowly and manage “activation” side effects

  • Common troubleshooting theme: early folinic acid/lucovorin can temporarily increase monoamines/glutamate, potentially worsening agitation and insomnia
  • Management approach described:
    • Reduce dose and hold longer
    • Keep working on upstream drivers (infection/inflammation/glutamate excess)
    • Resume slower titration later
  • Dosing example mentioned (general protocol):
    • Start 2.5 mg morning for 2–3 days
    • Then 2.5 mg morning + 2.5 mg afternoon for 3–4 days
    • Then increase gradually
  • Maximum referenced: up to about 25 mg twice daily (with clinician discretion)

7) Address glutamate excitotoxicity and microglial activation

  • The strategy links agitation-related symptoms—such as irritability, agitation, anxiety, insomnia, and “agitated” behavior—to glutamate excess.
  • Mechanism described: glutamate excitotoxicity may be driven by infection/inflammatory cytokines that activate microglia.
  • Tools mentioned (examples):
    • Magnesium (L-threonate) and P5P (vitamin B6 form)
    • Inositol (high doses mentioned)
    • Amantadine (sometimes helpful)
  • Emphasis: treat upstream causes (e.g., strep sources beyond typical swabs)

8) Reduce oxidative stress with antioxidants (NAC emphasized)

  • Antioxidant strategy:
    • NAC (acetylcysteine) described as a cornerstone for oxidative stress in the brain
    • Note: dosing may need to be high in OCD-like contexts, and adherence can be difficult in children
  • Inflammation markers mentioned:
    • Serum cytokines (e.g., IL-6, TNF-α) were described as imperfect but informative

9) Mitochondrial support as a “transport + energy” enabler

  • Rationale: folate transport mechanisms require energy (ATP/mitochondrial function)
  • Examples mentioned:
    • Carnitine (especially in children who don’t eat meat)
    • CoQ10 (ubiquinol) and B vitamins
  • “Zoom out/zoom in” described: reduce what’s stressing the cell first (infection, inflammation, toxicants such as heavy metals, mold, mycotoxins), then support downstream processes

10) Dietary precautions: avoid folic-acid–fortified foods; consider dairy/camel milk

  • Avoid: foods fortified with folic acid (per the described clinical context)
  • Dairy discussion:
    • Initially avoid animal dairy if FRAAs/CFD is suspected (cow/ovine/goat/camel/human discussed as having been associated with FRAAs in research)
    • Not necessarily lifelong; individualized by dose/load and immune response
  • Fortification nuance: fortification is generally not with folinic acid/methylated folate

11) Pre- and pregnancy planning (preconception emphasis)

  • Strategy described:
    • If mothers have FRAAs, consider a folate strategy before/during pregnancy
    • Preconception preparation framed as potentially routine standard of care
  • Additional framing mentioned: mothers with one affected child may have a higher likelihood of additional affected pregnancies (as described by the guest)

12) Daily self-care practices (the guest’s own wellness)

  • Maintain basics:
    • Protect sleep
    • Rise early
    • Study/solo time
    • Spend time in nature/forests
    • Walk with animals
    • “Weed out” stressors and reduce unnecessary commitments
    • Improve home cooking (noted as an area she’s working on)

Presenters / sources mentioned

People

  • Presenter/Guest: Dr. Emily Gutierrez, DNP (doctorally prepared nurse practitioner; functional medicine clinician)
  • Host: Scott (“Scott, your better health guy”; Better Health Guide podcast)

Research and organizations referenced (examples named in subtitles)

  • New England Journal of Medicine (2004 folate-in-the-brain research article)
  • American College of Obstetrics and Gynecology (ACOG) (pregnancy folic acid recommendation referenced)
  • Italian researchers (pregnancy cohort study described)
  • MAPS / Medical Academy of Pediatric Special Needs
  • Dr. Fry
  • Dr. Rosnol (and a meta-analysis by Rosnol/Fry referenced)
  • Vincent Raymakers
  • Edward Cuadros
  • Lindseay Wells
  • Elizabeth Hinchi
  • Dr. Nancy O’Hara
  • Dr. Wells (referenced on other cohorts)
  • Dr. Cuadro (family clustering noted)
  • Dong and Associates (mentioned regarding genetics/variants and risk)
  • Dr. Sharon Houseman Cohen (IntelXDNA referenced; credited with a folate antibody profile panel)

Testing company referenced

  • ReliGen (FRAT test; “fratt.com” referenced)

Original video